n-undecano, mínimo 95 %, para síntesis, 500 ml, envase de vidrio

1-(1-Isopropylpiperidin-4-yl)-1h-pyrazol-5-amine, 98%, 250mg

3-Ethyl-3-oxetanemethanol>96.0%(GC)100g

1-(4-Fluorophenyl)ethylamine, 97.0%, 1g

4-(2-Aminoethyl)thiomorpholine, 95.0%, 1g

2-Chloro-5-(4-chlorophenyl)pyrimidine, 95.0%, 10g

ETHYL 4-OXO-5,6,7,8-TETRAHYDRO-4H-PYRAZOLO[1,5-A][1,4]DIAZEPINE-2-CARBOXYLATE, 95.0%, 2g

2-Methylhexane>99.0%(GC)5mL

tert-Butyl 3-amino-3-cyanopyrrolidine-1-carboxylate, 95.0%, 100mg

4-Acetylimidazole, 97.0%, 10g

3-Bromo-N-(piperidin-4-yl)benzenesulfonamide hydrochloride, 95.0%, 1g

3-Chloro-N-methoxy-N-methylbenzamide, 95.0%, 100g

4-Butylphenyl Isocyanate>98.0%(GC)1g